Related Experiment Videos
Epidemiology of hepatitis C virus infection
1Liver Unit, Hospital General Vall d'Hebron, Universitat Autonoma de Barcelona, Spain.
Insights
Hepatitis C virus (HCV) causes most non-A, non-B hepatitis and chronic liver disease. Further research is needed on HCV transmission and its role in hepatocellular carcinoma (HCC).
Area of Science:
- Hepatology
- Virology
- Epidemiology
Background:
- Hepatitis C virus (HCV) is a significant cause of liver disease.
- The discovery of the anti-HCV assay has clarified the epidemiology of non-A, non-B hepatitis (NANB).
Purpose of the Study:
- To summarize the current understanding of HCV epidemiology and its role in liver disease.
- To highlight areas requiring further investigation, including transmission and co-factor roles.
Main Methods:
- Review of existing data and studies on HCV epidemiology.
- Analysis of anti-HCV assay results in various patient populations.
Main Results:
- HCV is the primary cause of post-transfusion and sporadic NANB hepatitis.
- HCV is implicated in most unidentified chronic liver disease cases.
- HCV may act as a co-factor in alcohol-related, viral, and autoimmune liver diseases.
- HCV is a significant co-factor in hepatocellular carcinoma (HCC) development.
Conclusions:
- HCV is a major etiological agent in chronic liver disease and HCC.
- Further studies are essential to elucidate HCV transmission routes (perinatal, sexual) and its role in neoplastic transformation.
Abstract:
The availability of the anti-HCV assay has confirmed most of the suspicions and predictions regarding the epidemiology of NANB hepatitis virus made before the discovery of HCV. It is now clear that HCV is responsible for the majority of cases of post-transfusion and sporadic NANB hepatitis, as well as of most cases of unidentified chronic liver disease. It seems plausible that HCV may act as a negative co-factor in other chronic liver diseases, especially those caused by alcohol, other hepatitis viruses, and so-called 'autoimmune hepatitis'. The issue of perinatal and sexual transmission of HCV has not yet been clarified, and further studies are urgently needed. Finally, the high prevalence of anti-HCV detected in HCC suggests that HCV is a major co-factor in the development of HCC and again raises the issue of viral persistence and neoplastic transformation, an issue that for HBV has not yet been elucidated.